Skip to content

Phoenix Life Sciences International Limited.

company.status.inactive

CIK 1493212fmd_197Q2R2BZTPT0AW1DTV2N2G65RManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard

Coverage: Mar 01, 2010 to Feb 28, 2019, 35 periods

Latest annual · FY2019

Millions
Total revenues
0
Gross profit
0
Operating income
(3)
Net income
(3)

Latest quarter · Q4 FY2019

Millions
Operating income
(1)
Net income
0
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2016 to FY2019
n/m
Revenue, 5 yearsFY2014 to FY2019
n/m
Net income, 5 yearsFY2014 to FY2019
n/m

Phoenix Life Sciences International Limited. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2019FY2018ChangeSource
Revenue$0$010-K 2020-04-10 · proof
Gross profit$0$010-K 2020-04-10 · proof
Operating income-$3.1 million-$45810-K 2020-04-10 · proof
Net income-$3.1 million-$76,59010-K 2020-04-10 · proof
Cash from operating activities-$860,030-$45810-K 2020-04-10 · proof
Total assets$11.4 million$236,449+4,736.8%10-K 2020-04-10 · proof
Total liabilities$1.3 million$1.6 million-15.8%10-K 2020-04-10 · proof
Cash and cash equivalents$201,988$697+28,879.6%10-K 2020-04-10 · proof
What was Phoenix Life Sciences International Limited.'s revenue in fiscal 2019?
Phoenix Life Sciences International Limited. reported revenue of $0 for fiscal 2019 (the year ended Feb 28, 2019), against $0 the year before. Source: the 10-K filed with the SEC on Apr 10, 2020. SEC
What was Phoenix Life Sciences International Limited.'s gross profit in fiscal 2019?
Phoenix Life Sciences International Limited. reported gross profit of $0 for fiscal 2019 (the year ended Feb 28, 2019), against $0 the year before. Source: the 10-K filed with the SEC on Apr 10, 2020. SEC
What was Phoenix Life Sciences International Limited.'s operating income in fiscal 2019?
Phoenix Life Sciences International Limited. reported operating income of -$3.1 million for fiscal 2019 (the year ended Feb 28, 2019), against -$458 the year before. Source: the 10-K filed with the SEC on Apr 10, 2020. SEC
What was Phoenix Life Sciences International Limited.'s net income in fiscal 2019?
Phoenix Life Sciences International Limited. reported net income of -$3.1 million for fiscal 2019 (the year ended Feb 28, 2019), against -$76,590 the year before. Source: the 10-K filed with the SEC on Apr 10, 2020. SEC
What was Phoenix Life Sciences International Limited.'s cash from operating activities in fiscal 2019?
Phoenix Life Sciences International Limited. reported cash from operating activities of -$860,030 for fiscal 2019 (the year ended Feb 28, 2019), against -$458 the year before. Source: the 10-K filed with the SEC on Apr 10, 2020. SEC
What are Phoenix Life Sciences International Limited.'s total assets?
As of Feb 28, 2019, Phoenix Life Sciences International Limited. reported total assets of $11.4 million, against $236,449 a year earlier (+4,736.8%). Source: the 10-K filed with the SEC on Apr 10, 2020. SEC
What are Phoenix Life Sciences International Limited.'s total liabilities?
As of Feb 28, 2019, Phoenix Life Sciences International Limited. reported total liabilities of $1.3 million, against $1.6 million a year earlier (-15.8%). Source: the 10-K filed with the SEC on Apr 10, 2020. SEC
What are Phoenix Life Sciences International Limited.'s cash and cash equivalents?
As of Feb 28, 2019, Phoenix Life Sciences International Limited. reported cash and cash equivalents of $201,988, against $697 a year earlier (+28,879.6%). Source: the 10-K filed with the SEC on Apr 10, 2020. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1493212&period_type=annual&limit=5"

Information only, not investment advice.